Search results for "Immunization"
MKSAP Quiz: Evaluation for multiple myeloma
A 64-year-old man is evaluated following a recent diagnosis of multiple myeloma. Chemotherapy is planned to begin in 14 days. Which prophylactic therapy is indicated today?
https://immattersacp.org/weekly/archives/2023/12/05/3.htm
5 Dec 2023
One-fifth of COVID-19 patients taking nirmatrelvir-ritonavir had viral rebound
A small observational study of ambulatory patients with COVID-19 found that 1.8% of untreated patients tested positive again after testing negative, compared to 20.8% of those who took five days of nirmatrelvir-ritonavir.
https://immattersacp.org/weekly/archives/2023/11/14/4.htm
14 Nov 2023
New findings on antiviral flu treatment
A recent study raises doubts about whether oseltamivir should be promoted as a way to prevent hospitalization in low-risk patients.
https://immattersacp.org/archives/2023/11/new-findings-on-antiviral-flu-treatment.htm
1 Nov 2023
The human right to health
The intrinsic connection between health and life's quintessential pursuits is undeniable.
https://immattersacp.org/archives/2023/11/the-human-right-to-health.htm
1 Nov 2023
Nominees named for College Officer and Regent positions
The Governance Committee of the American College of Physicians places in nomination the following candidates for College governance.
https://immattersacp.org/archives/2023/11/nominees-named-for-college-officer-and-regent-positions.htm
1 Nov 2023
New COVID-19 boosters, DNA test for cancer risk OK’ed
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/11/new-covid-19-boosters-dna-test-for-cancer-risk-oked.htm
1 Nov 2023
Latest COVID-19 studies show need for repeat rapid testing, targeting of antiviral prescriptions
Viral load of SARS-CoV-2 doesn't peak until the fourth day of symptoms, one study found, while other research only saw an effect of nirmatrelvir/ritonavir on death and hospitalization among those who were moderately or severely immunocompromised, not in other high-risk groups.
https://immattersacp.org/weekly/archives/2023/10/03/2.htm
3 Oct 2023
RSV vaccines new tool for physicians
The CDC's Advisory Committee on Immunization Practices recommended in June that adults ages 60 years and older may receive a single dose of an RSV vaccine, using shared clinical decision making.
https://immattersacp.org/archives/2023/10/rsv-vaccines-new-tool-for-physicians.htm
1 Oct 2023
New vaccines are on the scene
This month's issue addresses new vaccines, screening for anxiety, and detecting and treating loneliness.
https://immattersacp.org/archives/2023/10/new-vaccines-are-on-the-scene.htm
1 Oct 2023
Raising awareness about HPV-related cancers
The human papillomavirus (HPV) vaccine can potentially prevent more than 90% of HPV-associated cancers. Generally given to teens, it can be offered to adults as well.
https://immattersacp.org/archives/2023/10/raising-awareness-about-hpv-related-cancers.htm
1 Oct 2023